{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:52:10Z","timestamp":1789581130936,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013806","name":"Shenyang Pharmaceutical University","doi-asserted-by":"publisher","award":["YQ202208"],"award-info":[{"award-number":["YQ202208"]}],"id":[{"id":"10.13039\/501100013806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA0909900"],"award-info":[{"award-number":["2021YFA0909900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474205"],"award-info":[{"award-number":["82474205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biomaterials.2025.123862","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:52:58Z","timestamp":1763765578000},"page":"123862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Nano-in-microalgae integrated modular hydrogel system for spatiotemporally targeted oral gene therapy of ulcerative colitis"],"prefix":"10.1016","volume":"328","author":[{"given":"Weili","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonggui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7494-3963","authenticated-orcid":false,"given":"Jin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qikun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biomaterials.2025.123862_bib1","doi-asserted-by":"crossref","first-page":"874","DOI":"10.14309\/ajg.0000000000000183","article-title":"A treat-to-target update in ulcerative colitis: a systematic review","volume":"114","author":"Ungaro","year":"2019","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123862_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123862_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.crohns.2013.09.001","article-title":"National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States","volume":"8","author":"Nguyen","year":"2014","journal-title":"J. Crohns Colitis"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123862_bib4","article-title":"Design strategies, advances and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease","volume":"19","author":"Zheng","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123862_bib5","first-page":"280","article-title":"Berberine inhibits phagocytosis through the TLR4-PI3K-CDC42 pathway","volume":"4","author":"Chang","year":"2025","journal-title":"Acta. Mater. Medica"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123862_bib6","doi-asserted-by":"crossref","first-page":"102652","DOI":"10.1016\/j.xcrp.2025.102652","article-title":"Nano-bacteria hybrid materials for inflammatory bowel disease therapy","volume":"6","author":"Jiang","year":"2025","journal-title":"Cell Rep. Phys. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123862_bib7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/PAS.0b013e318150d51b","article-title":"Hyperplastic\/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity","volume":"32","author":"Srivastava","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123862_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41575-023-00889-7","article-title":"Are all the IL-23 blockers the same in inflammatory bowel disease?","volume":"21","author":"Danese","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123862_bib9","first-page":"1144","article-title":"P587 development and characterization of a novel extended half-life monoclonal antibody drug candidate targeting integrin \u02514\u03b27 for the treatment of IBD","volume":"18","author":"Zhu","year":"2024","journal-title":"J. Crohns Colitis"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123862_bib10","article-title":"Dual pH and microbial-sensitive galactosylated polymeric nanocargoes for multi-level targeting to combat ulcerative colitis","volume":"18","author":"Zeeshan","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123862_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/flgastro-2018-101054","article-title":"Recent advances in monoclonal antibody therapy in IBD: practical issues","volume":"10","author":"Tamilarasan","year":"2019","journal-title":"Frontline Gastroenterol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123862_bib12","first-page":"85","article-title":"The development and quality control of antibody-drug conjugates","volume":"34","author":"Wang","year":"2014","journal-title":"China Biotechnol."},{"key":"10.1016\/j.biomaterials.2025.123862_bib13","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1093\/ecco-jcc\/jjad212.1179","article-title":"P1049 Effectiveness and safety of subcutaneous infliximab in Crohn's disease patients with immunogenic failure of intravenous infliximab","volume":"18","author":"Husman","year":"2024","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.biomaterials.2025.123862_bib14","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/ecco-jcc\/jjad212.1033","article-title":"P903 persistence, efficacy and tolerance of subcutaneous infliximab after switch from intravenous infliximab in IBD patients in remission: one-year results from a multicenter prospective cohort","volume":"18","author":"Mathieu","year":"2024","journal-title":"J. Crohns Colitis"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123862_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s11671-019-2985-z","article-title":"Cationic micelle-based siRNA delivery for efficient colon cancer gene therapy","volume":"14","author":"Lu","year":"2019","journal-title":"Nanoscale Res. Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123862_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2217\/nmt-2018-0033","article-title":"Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis","volume":"9","author":"Kristen","year":"2019","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.biomaterials.2025.123862_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114432","article-title":"The growth of siRNA-based therapeutics: updated clinical studies","volume":"189","author":"Zhang","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123862_bib18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.5009\/gnl230291","article-title":"Effectiveness of switching to subcutaneous infliximab in ulcerative colitis patients experiencing intravenous infliximab failure","volume":"18","author":"Bae","year":"2024","journal-title":"Gut Liver"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123862_bib19","article-title":"Chemical-electron-transfer-based lipopolyplexes for enhanced siRNA delivery","volume":"4","author":"Zhang","year":"2023","journal-title":"Cell Rep. Phys. Sci."},{"key":"10.1016\/j.biomaterials.2025.123862_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115291","article-title":"Lipid nanoparticles for RNA delivery: self-assembling vs driven-assembling strategies","volume":"208","author":"Nele","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123862_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.apsb.2018.06.005","article-title":"Adapting liposomes for oral drug delivery","volume":"9","author":"He","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2025.123862_bib22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jconrel.2022.09.024","article-title":"Mucoadhesive carriers for oral drug delivery","volume":"351","author":"Kumar","year":"2022","journal-title":"J. Contr. Release"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123862_bib23","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2025.123862_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.54254\/2753-8818\/22\/20231005","article-title":"Review of the research and development status of siRNA drugs for gene therapy","volume":"22","author":"Peng","year":"2023","journal-title":"Theor. Nat. Sci."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123862_bib25","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41419-020-03032-5","article-title":"Lysosomal quality control of cell fate: a novel therapeutic target for human diseases","volume":"11","author":"Zhu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"24","key":"10.1016\/j.biomaterials.2025.123862_bib26","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cub.2017.11.012","article-title":"Detection and clearance of damaged lysosomes by the endo-lysosomal damage response and lysophagy","volume":"27","author":"Papadopoulos","year":"2017","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123862_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2249.2006.03188.x","article-title":"L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo","volume":"146","author":"Menzel","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123862_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106485","article-title":"A cathepsin B\/GSH dual-responsive fluorinated peptide for effective siRNA delivery to cancer cells","volume":"135","author":"Shi","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biomaterials.2025.123862_bib29","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1007\/s00044-023-03116-9","article-title":"Glutathione and glutathione disulfide \u2013 their biomedical and pharmaceutical applications","volume":"32","author":"Guan","year":"2023","journal-title":"Med. Chem. Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123862_bib30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/pi.6332","article-title":"Cathepsin B and thermal dual-stimuli responsive linear-dendritic block copolymer micelles for anticancer drug delivery","volume":"71","author":"Song","year":"2022","journal-title":"Polym. Int."},{"key":"10.1016\/j.biomaterials.2025.123862_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2020.109356","article-title":"Spirulina for the food and functional food industries","volume":"137","author":"Lafarga","year":"2020","journal-title":"Food Res. Int."},{"key":"10.1016\/j.biomaterials.2025.123862_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjad212.1282","article-title":"P1152 health-related quality of life among Irish inflammatory bowel disease patients: a cross-sectional survey using the EQ-5D-5L","volume":"18","author":"Mallon","year":"2024","journal-title":"J. Crohns Colitis"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123862_bib33","doi-asserted-by":"crossref","first-page":"101979","DOI":"10.1016\/j.xcrp.2024.101979","article-title":"Natural algae-inspired microrobots for emerging biomedical applications and beyond","volume":"5","author":"Li","year":"2024","journal-title":"Cell Rep. Phys. Sci."},{"issue":"48","key":"10.1016\/j.biomaterials.2025.123862_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi9265","article-title":"Orally deliverable strategy based on microalgal biomass for intestinal disease treatment","volume":"7","author":"Zhong","year":"2021","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123862_bib35","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1021\/acsnano.3c01502","article-title":"Oral microalgae-nano integrated system against radiation-induced injury","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123862_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130274","article-title":"Synthesis, characterization, and application of honey stabilized inulin nanoparticles as colon targeting drug delivery carrier","volume":"263","author":"Joseph","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biomaterials.2025.123862_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.129131","article-title":"Inulin: unveiling its potential as a multifaceted biopolymer in prebiotics, drug delivery, and therapeutics","volume":"259","author":"Akram","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biomaterials.2025.123862_bib38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijbiomac.2020.12.094","article-title":"Macrophages-targeting mannosylated nanoparticles based on inulin for the treatment of inflammatory bowel disease (IBD)","volume":"169","author":"Sun","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123862_bib39","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.apsb.2025.04.003","article-title":"Self-degradable \u201cgemini-like\u201d ionizable lipid-mediated delivery of siRNA for subcellular-specific gene therapy of hepatic diseases","volume":"15","author":"Wang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"39","key":"10.1016\/j.biomaterials.2025.123862_bib40","doi-asserted-by":"crossref","first-page":"14717","DOI":"10.1039\/D1NR05644A","article-title":"Gemini lipid nanoparticle (GLNP)-mediated oral delivery of TNF-\u03b1 siRNA mitigates gut inflammation via inhibiting the differentiation of CD4+ T cells","volume":"14","author":"Verma","year":"2022","journal-title":"Nanoscale"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123862_bib41","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1016\/j.cclet.2022.03.061","article-title":"Emerging nanomedicine and prodrug delivery strategies for the treatment of inflammatory bowel disease","volume":"33","author":"Sun","year":"2022","journal-title":"Chin. Chem. Lett."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123862_bib42","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.7150\/thno.43716","article-title":"Parthenolide ameliorates colon inflammation through regulating Treg\/Th17 balance in a gut microbiota-dependent manner","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123862_bib43","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nmat2859","article-title":"Orally delivered thioketal nanoparticles loaded with TNF-\u03b1\u2013siRNA target inflammation and inhibit gene expression in the intestines","volume":"9","author":"Wilson","year":"2010","journal-title":"Nat. Mater."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123862_bib44","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1023\/B:DDAS.0000042248.48819.ad","article-title":"Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats","volume":"49","author":"Rumi","year":"2004","journal-title":"Dig. Dis. Sci."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225007823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225007823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:49:23Z","timestamp":1781326163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225007823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":44,"alternative-id":["S0142961225007823"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123862","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nano-in-microalgae integrated modular hydrogel system for spatiotemporally targeted oral gene therapy of ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"123862"}}